Ipratropium Bromide was first introduced by Boehringer Ingelheim Pharmaceuticals Inc in its drug Atrovent on Dec 29, 1986. Another drug containing Ipratropium Bromide is Atrovent Hfa. 19 different companies have introduced drugs containing Ipratropium Bromide.

Ipratropium Bromide Patents

Given below is the list of patents protecting Ipratropium Bromide, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Atrovent Hfa	US8474447	Inhaler device	Jan 17, 2030	Boehringer Ingelheim
Atrovent Hfa	US6739333	Stainless steel canister for propellant-driven metering aerosols	May 26, 2020 (Expired)	Boehringer Ingelheim
Atrovent Hfa	US6983743	Stainless steel canister for propellant-driven metering aerosols	May 26, 2020 (Expired)	Boehringer Ingelheim
Atrovent Hfa	US5683677	Medicinal aerosol formulations	Nov 04, 2014 (Expired)	Boehringer Ingelheim
Atrovent Hfa	US5676930	Stabilized medicinal aerosol solution formulations	Oct 14, 2014 (Expired)	Boehringer Ingelheim

Add above patents to watchlist

Ipratropium Bromide's Family Patents

Full family tree

Ipratropium Bromide Generic API Manufacturers

Several generic applications have been filed for Ipratropium Bromide. The first generic version for Ipratropium Bromide was by Pharmobedient Consulting Llc and was approved on Jan 10, 1997. And the latest generic version is by Lupin Inc and was approved on Feb 7, 2025.

Given below is the list of companies who have filed for Ipratropium Bromide generic, along with the locations of their manufacturing plants worldwide.